Arene Life Sciences (Unit 3) Private Limited

Arene Life Sciences (Unit 3) Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24239TG2006PTC049202 Incorporated 20 February 2006 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹287.8 Cr
▲ 53% YoY
Net profit · FY 2025
₹14.42 Cr
Net margin 5%
EBITDA · FY 2025
₹35 Cr
EBITDA margin 12.2%
Authorised capital
₹12 Cr
Registered with MCA
Paid-up capital
₹10.83 Cr
Issued & subscribed
Open charges
₹143.4 Cr
Satisfied ₹43 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
368
Provident fund records

About Arene Life Sciences (Unit 3) Private Limited

Data last updated:

Arene Life Sciences (Unit 3) Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 20 February 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2006PTC049202. Its GSTIN is 36AAFCA6947C1ZQ (Telangana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹12 Cr and a paid-up capital of ₹10.83 Cr. It was formerly known as A V R Organics Private Limited. It is led by directors including Satyanarayana Reddy Khairtabad and Santosh Reddy Chinnamail.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.3 – 58 S.R. Chambers R.C.Puram Main Road, Hyderabad, Telangana, India – 502032.

As per the financials filed for FY 2025, the company reported a revenue of ₹287.8 Cr, a growth of 53% compared to the previous year. For the same year it recorded a net profit of ₹14.42 Cr (net margin 5%) and EBITDA of ₹35 Cr (EBITDA margin 12.2%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 21% over five years.

The company has about 368 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹143.4 Cr and satisfied charges of ₹43 Cr on record. Court records list 6 cases involving the company, including 3 filed by the company and 3 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website srdrugs.in.

Company details

CIN U24239TG2006PTC049202
Registration Number 049202
Incorporation Date 20 February 2006
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant

CIN history

Arene Life Sciences (Unit 3) has one previous CIN (Corporate Identification Number): U24239AP2006PTC049202. The current CIN is U24239TG2006PTC049202, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239TG2006PTC049202Current
U24239AP2006PTC049202Previous

Contact details

Arene Life Sciences (Unit 3) Private Limited's registered office is in Hyderabad, Telangana. Its website is srdrugs.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Registered Address
    No.3 – 58 S.R. Chambers R.C.Puram Main Road, Hyderabad, Telangana, India – 502032
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Arene Life Sciences (Unit 3) Private Limited, buy the company report.

Comprehensive company report
Arene Life Sciences (Unit 3) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Arene Life Sciences (Unit 3) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Arene Life Sciences (Unit 3) Private Limited, buy the company report.

Financials of Arene Life Sciences (Unit 3) Private Limited

FY 2024 filings available

Arene Life Sciences (Unit 3) Private Limited reported revenue of ₹287.8 Cr (up 53% YoY) for FY 2025.

Revenue · FY 2025
₹287.8 Cr ▲ 53%
Net profit · FY 2025
₹14.42 Cr margin 5%
EBITDA · FY 2025
₹35 Cr margin 12.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 53%
3 years · compounded
▲ 21%
5 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▲ 60%
3 years · compounded
▲ 15%
5 years · compounded
▲ 20%

Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 53% growth in the latest year. EBITDA rose 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹35 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹14.42 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin12.2%
Net Profit Margin5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Arene Life Sciences (Unit 3) Private Limited, buy the company report.

Board of directors of Arene Life Sciences (Unit 3) Private Limited

Arene Life Sciences (Unit 3) has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Satyanarayana Reddy KhairtabadDirector02 Sep 20179 Years 1 MonthsCurrent
Santosh Reddy ChinnamailDirector19 Feb 20206 Years 8 MonthsCurrent
Khairtabad Anuraag ReddyDirector19 Feb 20206 Years 8 MonthsCurrent
Purushotam AngalaguthaDirector04 Jan 20188 Years 9 MonthsCurrent
Satyanarayana Reddy ChinnamailDirector02 Sep 20179 Years 1 MonthsCurrent

Peer comparison

Arene Life Sciences (Unit 3) Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Optrix Laboratories Private Limited₹304.7 Cr (FY 2020)43.0%Hyderabad, Telangana, India
Ajinomoto Bio-Pharma Services India Private Limited₹301.41 Cr (FY 2025)56.0%Anakapalle, Andhra Pradesh, India
Alembic Limited₹296.78 Cr (FY 2025)40.0%Vadodara, Gujarat, India
Anjan Drug Private Limited₹293.42 Cr (FY 2025)-14.0%Chengalpattu Dt, Tamil Nadu, India
Arene Life Sciences (Unit 3) Private Limitedthis company₹287.8 Cr (FY 2025)₹14.42 Cr5%53.0%368Hyderabad, Telangana, India
Cdymax (India) Pharma Private Limited₹284.85 Cr (FY 2025)12.0%Bangalore, Karnataka, India
Vijayasri Organics Private Limited₹280.5 Cr (FY 2025)16.0%Hyderabad, Telangana, India
Jagson Pal Pharmaceuticals Limited.₹276.91 Cr (FY 2025)27.0%New Delhi, Delhi, India
Embio Limited₹274.76 Cr (FY 2025)49.0%Mumbai, Maharashtra, India

To see the full peer comparison of Arene Life Sciences (Unit 3) Private Limited, buy the company report.

Auditor

Arene Life Sciences (Unit 3) Private Limited is audited by GLN Prasad & Co LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
GLN Prasad & Co LLPFY 2023015176S/S200067

Shareholding

The shareholding of Arene Life Sciences (Unit 3) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Arene Life Sciences (Unit 3) Private Limited, buy the company report.

Charges & borrowings

Open charges
₹143.4 Cr
Satisfied charges
₹43 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹66.30 Cr
Karnataka Bank Ltd.₹57.10 Cr
Others₹20.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
22 Apr 2025101087177Hdfc Bank Limited₹30 LakhOpen
11 Apr 2025101076839Others₹20 CrOpen
30 Dec 2021100532548Karnataka Bank Ltd.₹8.9 CrOpen
24 Sep 2021100485745Hdfc Bank Limited₹66 CrOpen
21 Apr 2020100335986Karnataka Bank Ltd.₹48.2 CrOpen

To see the full charge records of Arene Life Sciences (Unit 3) Private Limited, buy the company report.

Total charge records: 13 View all charges

Credit ratings & regulatory alerts

Arene Life Sciences (Unit 3) Private Limited was last rated by Indiarating on 26 Aug 2021.

Rating agencyRated onRating
Indiarating26 Aug 2021

To see the full credit ratings and regulatory alerts of Arene Life Sciences (Unit 3) Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Arene Life Sciences (Unit 3) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Arene Life Sciences (Unit 3) Private Limited has a workforce of 368 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.

Employee count
368
Active EPFO establishments
1
Employee growth
62.11%

GST

Arene Life Sciences (Unit 3) has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AAFCA6947C1ZQTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Arene Life Sciences (Unit 3) Private Limited, buy the company report.

Recent activity

Arene Life Sciences (Unit 3) Private Limited has 10 board changes on record since 2017: 5 appointments and 5 cessations. The latest: Khairtabad Anuraag Reddy was appointed as Director on 19 Feb 2020.

Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 101087177 was registered on 22 Apr 2025.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101076839 was registered on 11 Apr 2025.
AGM
Arene Life Sciences (Unit 3) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Arene Life Sciences (Unit 3) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge registered on 03 Sep 2020 via Charge ID 100365651 with Karnataka Bank Ltd. was fully satisfied on 29 Apr 2022.
Charges
A charge registered on 30 Mar 2011 via Charge ID 10285589 with Karnataka Bank Ltd. was fully satisfied on 29 Apr 2022.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 8.90 Cr with Charge ID 100532548 was registered on 30 Dec 2021.
Charges
A charge with Hdfc Bank Limited of Rs. 66.00 Cr registered on 24 Sep 2021 with Charge ID 100485745 was modified on 07 Dec 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 66.00 Cr with Charge ID 100485745 was registered on 24 Sep 2021.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 2.72 Cr with Charge ID 100365651 was registered on 03 Sep 2020.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 48.20 Cr with Charge ID 100335986 was registered on 21 Apr 2020.
Appointed
Khairtabad Anuraag Reddy was appointed as Director.

26 earlier events are in the company report.

Frequently asked questions

Arene Life Sciences (Unit 3) is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 20 February 2006 (20+ years old) and is registered under CIN U24239TG2006PTC049202.

Arene Life Sciences (Unit 3) has 5 current directors:

The latest financial statements of Arene Life Sciences (Unit 3) on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Arene Life Sciences (Unit 3) is 36AAFCA6947C1ZQ, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Arene Life Sciences (Unit 3) is U24239TG2006PTC049202. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Arene Life Sciences (Unit 3) has 6 court cases on record: 3 filed by the company and 3 filed against it. Most are in the high courts.

Arene Life Sciences (Unit 3) was incorporated on 20 February 2006, making it 20+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Arene Life Sciences (Unit 3) by revenue are Optrix Laboratories Private Limited, Ajinomoto Bio-Pharma Services India Private Limited, Alembic Limited, Anjan Drug Private Limited, Cdymax (India) Pharma Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Khairtabad Anuraag Reddy was appointed as Director on 19 Feb 2020. Santosh Reddy Chinnamail was appointed as Director on 19 Feb 2020. Purushotam Angalagutha ceased to be Additional Director on 28 Sep 2018. Arene Life Sciences (Unit 3) has 10 board changes on record in total.

Arene Life Sciences (Unit 3) can be reached through the website srdrugs.in. Its registered office is in Hyderabad, Telangana, India.

The registered office of Arene Life Sciences (Unit 3) is at No.3 – 58 S.R. Chambers R.C.Puram Main Road, Hyderabad, Telangana, India – 502032.